Search clinical trials for: TLL018

Total 9 results

Hangzhou Highlightll Pharmaceutical Co., Ltd

Recruiting

The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

United States
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.

Chronic Spontaneous Urticaria

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

China
TLL Pharmaceutical, LLC

Completed

A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants

Healthy

United States
TLL Pharmaceutical, LLC

Withdrawn

Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis

Ulcerative Colitis

United States
Teligene US

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients

Solid Tumor
University of Aberdeen
NHS Grampian

Completed

Anti-psoriatic Effect of TL01 Light Therapy

Psoriasis

United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects

DLBCL

Bulgaria, Estonia, France, Hungary, Italy, Latvia, Poland, Russian Federation, Spain, Ukraine
Teva Pharmaceutical Industries, Ltd.

Completed

TL011 in Severe, Active Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Czechia, Hungary, Italy, Spain, United Kingdom

Search clinical trials for: TLL018

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations